ADOC regimen

WikiDoc Resources for ADOC regimen
Articles
Most recent articles on ADOC regimen Most cited articles on ADOC regimen Review articles on ADOC regimen Articles on ADOC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on ADOC regimen Images of ADOC regimen Photos of ADOC regimen Podcasts & MP3s on ADOC regimen Videos on ADOC regimen
Evidence Based Medicine
Cochrane Collaboration on ADOC regimen Bandolier on ADOC regimen TRIP on ADOC regimen
Clinical Trials
Ongoing Trials on ADOC regimen at Clinical Trials.gov Trial results on ADOC regimen Clinical Trials on ADOC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on ADOC regimen NICE Guidance on ADOC regimen NHS PRODIGY Guidance FDA on ADOC regimen CDC on ADOC regimen
Books
Books on ADOC regimen
News
ADOC regimen in the news Be alerted to news on ADOC regimen News trends on ADOC regimen
Commentary
Blogs on ADOC regimen
Definitions
Definitions of ADOC regimen
Patient Resources / Community
Patient resources on ADOC regimen Discussion groups on ADOC regimen Patient Handouts on ADOC regimen Directions to Hospitals Treating ADOC regimen Risk calculators and risk factors for ADOC regimen
Healthcare Provider Resources
Symptoms of ADOC regimen Causes & Risk Factors for ADOC regimen Diagnostic studies for ADOC regimen Treatment of ADOC regimen
Continuing Medical Education (CME)
CME Programs on ADOC regimen
International
ADOC regimen en Espanol ADOC regimen en Francais
Business
ADOC regimen in the Marketplace Patents on ADOC regimen
Experimental / Informatics
List of terms related to ADOC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Oncovin-Prednisone regimen

Overview

ADOC regimen refers to an immunochemotherapy regimen consisting of rituximab, cyclophosphamide, hydroxydaunorubicin hydrochloride (doxorubicin hydrochloride), vincristine (Oncovin) and prednisone used to treat both indolent and aggressive forms of non-Hodgkin lymphoma.

Regimen

R – Rituximab

C – Cyclophosphamide

H – Doxorubicin (Hydroxydaunomycin)

O – Vincristine (Oncovin)

P – Prednisone

Indications

• Diffuse large B-cell lymphoma, untreated
• Mantle cell lymphoma